Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

10x Genomics (TXG) Change in Receivables (2018 - 2026)

10x Genomics' Change in Receivables history spans 8 years, with the latest figure at -$17.3 million for Q4 2025.

  • On a quarterly basis, Change in Receivables rose 35.68% to -$17.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $34.9 million, a 229.4% increase, with the full-year FY2025 number at $34.9 million, up 229.4% from a year prior.
  • Change in Receivables hit -$17.3 million in Q4 2025 for 10x Genomics, down from -$16.3 million in the prior quarter.
  • Over the last five years, Change in Receivables for TXG hit a ceiling of $103.8 million in Q2 2025 and a floor of -$35.3 million in Q1 2025.
  • Historically, Change in Receivables has averaged $3.6 million across 5 years, with a median of $3.9 million in 2021.
  • Biggest five-year swings in Change in Receivables: tumbled 345.59% in 2024 and later skyrocketed 85189.34% in 2025.
  • Tracing TXG's Change in Receivables over 5 years: stood at $6.8 million in 2021, then skyrocketed by 202.14% to $20.6 million in 2022, then plummeted by 46.78% to $11.0 million in 2023, then tumbled by 345.59% to -$27.0 million in 2024, then surged by 35.68% to -$17.3 million in 2025.
  • Business Quant data shows Change in Receivables for TXG at -$17.3 million in Q4 2025, -$16.3 million in Q3 2025, and $103.8 million in Q2 2025.